New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Scientists reverse drug resistance in prostate cancer by targeting 'hijacked' white blood cells

Scientists reverse drug resistance in prostate cancer by targeting 'hijacked' white blood cells

byInstitute of Cancer ResearchScanning electron micrograph of a single prostate cancer cell. Credit:Anne Weston, Francis Crick InstituteProstate cancer's resistance to treatment can be
World medicine December 01,2023
Scientists reverse drug resistance in prostate cancer by targeting 'hijacked' white blood cells

Scientists reverse drug resistance in prostate cancer by targeting 'hijacked' white blood cells

byInstitute of Cancer ResearchScanning electron micrograph of a single prostate cancer cell. Credit:Anne Weston, Francis Crick InstituteProstate cancer's resistance to treatment can be
World medicine December 01,2023
Ranitidine study finds no elevated risk of cancer... despite finding elevated cancer rates

Ranitidine study finds no elevated risk of cancer... despite finding elevated cancer rates

by Justin Jackson , Medical XpressKaplan-Meier Plots for the Risk of All Cancer Except Nonmelanoma Skin Cancer Associated With Ranitidine Users and Other Histamine-2 Receptor Antagonist (H2RA) Users P
World medicine December 01,2023
Ranitidine study finds no elevated risk of cancer... despite finding elevated cancer rates

Ranitidine study finds no elevated risk of cancer... despite finding elevated cancer rates

by Justin Jackson , Medical XpressKaplan-Meier Plots for the Risk of All Cancer Except Nonmelanoma Skin Cancer Associated With Ranitidine Users and Other Histamine-2 Receptor Antagonist (H2RA) Users P
World medicine December 01,2023
Researchers show how cancer cells resist chemotherapy

Researchers show how cancer cells resist chemotherapy

by Ben Knight,University of New South WalesTiny tube-like structures inside the cell called microtubules (in green) that help separate chromosomes evenly during cell division can overcome low ex
World medicine December 01,2023
Researchers show how cancer cells resist chemotherapy

Researchers show how cancer cells resist chemotherapy

by Ben Knight,University of New South WalesTiny tube-like structures inside the cell called microtubules (in green) that help separate chromosomes evenly during cell division can overcome low ex
World medicine December 01,2023
Genomic tug of war could boost cancer therapy

Genomic tug of war could boost cancer therapy

byUniversity of Rochester Medical CenterCredit: CC0 Public DomainSome patients with myelodysplastic syndromes, like acute myeloid leukemia, benefit from a chemotherapy drug called decitabine tha
World medicine December 01,2023
Genomic tug of war could boost cancer therapy

Genomic tug of war could boost cancer therapy

byUniversity of Rochester Medical CenterCredit: CC0 Public DomainSome patients with myelodysplastic syndromes, like acute myeloid leukemia, benefit from a chemotherapy drug called decitabine tha
World medicine December 01,2023
Multinational study confirms association between CT scans in young people and increased risk of cancer

Multinational study confirms association between CT scans in young people and increased risk of cancer

byBarcelona Institute for Global HealthCredit: CC0 Public DomainA multinational study of almost one million individuals confirms a strong and clear association between exposure to radiation from
World medicine December 01,2023
Multinational study confirms association between CT scans in young people and increased risk of cancer

Multinational study confirms association between CT scans in young people and increased risk of cancer

byBarcelona Institute for Global HealthCredit: CC0 Public DomainA multinational study of almost one million individuals confirms a strong and clear association between exposure to radiation from
World medicine December 01,2023
Novel urine-based test offers new hope for bladder cancer patients

Novel urine-based test offers new hope for bladder cancer patients

by KeAi Communications Co.IOverview of establishment of BC-PD-L1. (A) Overview of the models of BCCs for potential applications in prediction of prognosis in bladder cancer. Urine/tumor samples
World medicine December 01,2023
Novel urine-based test offers new hope for bladder cancer patients

Novel urine-based test offers new hope for bladder cancer patients

by KeAi Communications Co.IOverview of establishment of BC-PD-L1. (A) Overview of the models of BCCs for potential applications in prediction of prognosis in bladder cancer. Urine/tumor samples
World medicine December 01,2023
Preventing collateral damage in cancer treatment

Preventing collateral damage in cancer treatment

by Kim Vallez Quintana,Sandia National LaboratoriesThe Electronic Polymer Dosimeter for Radiotherapy, created by a team at Sandia National Laboratories. Credit: Spencer ToyUsing a simple concept
World medicine December 01,2023
Preventing collateral damage in cancer treatment

Preventing collateral damage in cancer treatment

by Kim Vallez Quintana,Sandia National LaboratoriesThe Electronic Polymer Dosimeter for Radiotherapy, created by a team at Sandia National Laboratories. Credit: Spencer ToyUsing a simple concept
World medicine December 01,2023
AACR cancer progress report reveals 33 percent decrease in cancer death rate, 1990 to 2020

AACR cancer progress report reveals 33 percent decrease in cancer death rate, 1990 to 2020

by Elana GotkineThe age-adjusted overall cancer death rate in the United States decreased by 33 percent from 1991 to 2020, according to the annualAACRCancer Progress Report 2023publi
World medicine December 01,2023
AACR cancer progress report reveals 33 percent decrease in cancer death rate, 1990 to 2020

AACR cancer progress report reveals 33 percent decrease in cancer death rate, 1990 to 2020

by Elana GotkineThe age-adjusted overall cancer death rate in the United States decreased by 33 percent from 1991 to 2020, according to the annualAACRCancer Progress Report 2023publi
World medicine December 01,2023
Harnessing AI to help pinpoint cancerous tumors

Harnessing AI to help pinpoint cancerous tumors

byUniversity of WaterlooA schematic diagram of Safeghi Goughari's experimental setup. Credit: Moslem Sadeghi GoughariEngineers from the University of Waterloo are harnessing artificial intel
World medicine December 01,2023
Harnessing AI to help pinpoint cancerous tumors

Harnessing AI to help pinpoint cancerous tumors

byUniversity of WaterlooA schematic diagram of Safeghi Goughari's experimental setup. Credit: Moslem Sadeghi GoughariEngineers from the University of Waterloo are harnessing artificial intel
World medicine December 01,2023
New radiopharmaceutical shows antitumor activity in patients with advanced prostate cancer

New radiopharmaceutical shows antitumor activity in patients with advanced prostate cancer

byWeill Cornell Medical CollegeCredit: Unsplash/CC0 Public DomainResearchers at Weill Cornell Medicine have led a phase 1 trial of a new drug that delivers potent radiation therapy directly and
World medicine December 01,2023
New radiopharmaceutical shows antitumor activity in patients with advanced prostate cancer

New radiopharmaceutical shows antitumor activity in patients with advanced prostate cancer

byWeill Cornell Medical CollegeCredit: Unsplash/CC0 Public DomainResearchers at Weill Cornell Medicine have led a phase 1 trial of a new drug that delivers potent radiation therapy directly and
World medicine December 01,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com